Morgan Stanley Highlights Two New IPO Stocks

Summary

Morgan Stanley has highlighted two new IPO stocks: MNTN, Inc., a connected TV advertising platform, and Hinge Health, which focuses on musculoskeletal health. MNTN was listed on May 22, raising $187.2 million with a market value of $1.7 billion. Analyst Matthew Cost rates MNTN as neutral (hold) with a target price of $20, suggesting potential downside risk. Hinge Health aims to improve musculoskeletal health through personalized programs. The IPO market in 2025 is booming, with 161 IPOs so far, expected to surpass last year’s total of 225.Tip Ranks

Impact Analysis

The event indicates Morgan Stanley’s recognition of two newly public companies, MNTN and Hinge Health, which could influence investor sentiment and market perception. First-order effects include MNTN experiencing potential market volatility due to its neutral rating and the price target indicating downside risk. Hinge Health’s IPO and its mission to tackle musculoskeletal health care suggest a potential growth opportunity in the healthcare sector. Second-order effects could involve increased investor interest in the IPO market, given the booming activity in 2025. Investment opportunities may arise in the broader healthcare and tech sectors, capitalizing on the increasing number of IPOs and the potential growth areas highlighted by Morgan Stanley.Tip Ranks